Boaz Gur-Lavie, Chief Financial Officer at PLURISTEM THERAPEUTICS INC (PSTI), bought 1,250 shares at $2.75 ($3K) on 2014-09-16, disclosed to the SEC on 2014-09-17.
Open-market purchase of $3k PSTI by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.